Physician profile
William Lackey
NPI 1912014218
$4,581.58
in general payments reported to CMS, 2019-2025
10 companies · $39.23 in 2025
The $39.23 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,627 · 2020: $367 · 2021: $532 · 2022: $747 · 2023: $36.13 · 2024: $233 · 2025: $39.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,982.50 | 2019-2024 | |
| Horizon Therapeutics Plc | $1,472.62 | 2019-2022 | |
| Gotham Surgical Solutions & Devices, INC. | $388.32 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $199.57 | 2020-2024 | Xiaflex |
| Smith+Nephew, INC. | $170.07 | 2019 | |
| Suvon Surgical LLC | $147.54 | 2024 | |
| Depuy Synthes Sales INC. | $75.57 | 2020-2024 | Orthovisc |
| Pacira Therapeutics, INC. | $64.11 | 2021 | |
| Stryker Corporation | $42.05 | 2022 | |
| Endo USA, INC. | $39.23 | 2025 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Lackey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.